TEST ID PT217 Phospho-Tau 217, Plasma
Ordering Guidance
This assay is useful for individuals presenting with mild cognitive impairment or early dementia. Results must be interpreted in conjunction with other diagnostic tools such as neurological examination, neurobehavioral tests, imaging, and routine laboratory tests.
This assay should not be ordered for individuals younger than 50 years or in cognitively unimpaired individuals regardless of age.
This assay should not be used to predict the development of dementia or other neurologic conditions.
Specimen Required
Collection Container/Tube: Lavender top (EDTA)
Submission Container/Tube: Plastic screw-top vial
Specimen Volume: 0.6 mL
Collection Information: Centrifuge and aliquot plasma into plastic vial. Do not submit in original tube.
Useful For
Evaluation of individuals, aged 50 years and older, presenting with cognitive impairment who are being assessed for Alzheimer disease and other causes of cognitive decline
This test is not intended as a screening test for Alzheimer disease in asymptomatic individuals.
Method Name
Chemiluminescent Enzyme Immunoassay
Reporting Name
Phospho-Tau(217), PSpecimen Type
EDTA PlasmaSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
EDTA Plasma | Refrigerated (preferred) | 14 days | |
Frozen | 90 days | ||
Ambient | 72 hours |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | OK |
Gross icterus | OK |
Reference Values
Negative: ≤0.185 pg/mL
Intermediate: 0.186-0.324 pg/mL
Positive: ≥0.325 pg/mL
Day(s) Performed
Monday through Friday
Report Available
1 to 3 daysSpecimen Retention Time
3 monthsPerforming Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
84393
Forms
If not ordering electronically, complete, print, and send a Neurology Specialty Testing Client Test Request (T732) with the specimen.